643
Participants
Start Date
December 13, 2021
Primary Completion Date
March 5, 2025
Study Completion Date
October 25, 2028
Pembrolizumab
IV infusion
Paclitaxel
IV infusion
Bevacizumab
IV infusion
Placebo for pembrolizumab
IV infusion
Docetaxel
IV infusion
Institut Jules Bordet-Medicine Oncology ( Site 0302), Brussels
Auckland City Hospital ( Site 1901), Auckland
Westmead Hospital-Department of Gynaecological Oncology ( Site 0201), Westmead
UZ Leuven ( Site 0303), Leuven
Epworth Freemasons ( Site 0204), Melbourne
Gallipoli Medical Research Foundation-GMRF CTU ( Site 0202), Brisbane
St. John of God Subiaco Hospital ( Site 0203), Subiaco
AZ Groeninge Campus Kennedylaan-Oncology ( Site 0305), Kortrijk
UZ Gent-Medical oncology ( Site 0301), Ghent
Aalborg Universitetshospital, Syd ( Site 0901), Aalborg
Universitetssykehuset Nord-Norge HF-Kreftavdelingen ( Site 2001), Tromsø
Columbia University Medical Center ( Site 0010), New York
Ospedale Mauriziano-Ginecologia e Ostetricia ( Site 1507), Turin
Charité Campus Virchow-Klinikum ( Site 1201), Berlin
INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1701), Mexico City
Centre François Baclesse-Recherche clinique ( Site 2904), Caen
Roswell Park Cancer Institute ( Site 0039), Buffalo
University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0024), Pittsburgh
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1503), Milan
Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 1502), Milan
ASST Grande Ospedale Metropolitano Niguarda ( Site 1505), Milan
Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001), Turku
Ospedale San Gerardo-ASST Monza-Oncologia ( Site 1508), Monza
Mercy Medical Center - Baltimore-Medical Oncology and Hematology ( Site 0015), Baltimore
Inova Schar Cancer Institute ( Site 0019), Fairfax
Asklepios Kliniken Hamburg-Asklepios Klinik Barmbek ( Site 1214), Hamburg
Investigación Oncofarmacéutica-Investigación clínica ( Site 1706), La Paz
Azienda Ospedaliera Spedali Civili di Brescia ( Site 1504), Brescia
Novant Health Forsyth Medical Center ( Site 0057), Winston-Salem
Duke Cancer Institute ( Site 0038), Durham
Novant Health Presbyterian Medical Center ( Site 0029), Charlotte
Centre Hospitalier Régional Universitaire de Brest - Hôpital-Institut de cancérologie et hématologi, Brest
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0005), Marietta
University of Florida College of Medicine-UF Health Cancer Center/Clinical Trials Office ( Site 0054, Gainesville
Moffitt Cancer Center ( Site 0033), Tampa
Centre de Cancérologie du Grand Montpellier ( Site 2908), Montpellier
Bezmialem Vakf Üniversitesi-Oncology ( Site 2705), Istanbul
Istanbul Universitesi Cerrahpasa ( Site 2709), Fatih
Baskent Universitesi Ankara Hastanesi ( Site 2707), Ankara
Sarasota Memorial Hospital ( Site 0018), Sarasota
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma, Istanbul
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer-Medical Oncology ( Site 2901), Rennes
Ege University Medicine of Faculty ( Site 2702), Bornova
The West Clinic, PLLC dba West Cancer Center ( Site 0058), Germantown
IRCCS - AOU di Bologna-SSD Oncologia medica Addarii ( Site 1501), Bologna
Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1204), Düsseldorf
Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0040), Edgewood
MetroHealth Medical Center-Cancer Care Center ( Site 0047), Cleveland
Hôpital privé du Confluent SAS-Service d'oncologie médicale ( Site 2905), Nantes
Aultman Hospital-Oncology Clinical Trials ( Site 0009), Canton
St. Vincent Hospital and Health Care Center, Inc ( Site 0032), Indianapolis
Parkview Research Center at Parkview Regional Medical Center ( Site 0027), Fort Wayne
Zentrum fuer ambulante gynaekologische Onkologie (ZAGO) ( Site 1207), Krefeld
Rabin Medical Center ( Site 1401), Petah Tikva
Universitätsklinikum Bonn-Gynaecological oncology ( Site 1203), Bonn
Sanford Cancer Center ( Site 0064), Sioux Falls
Advocate Medical Group-Oncology ( Site 0049), Park Ridge
iCan Oncology Center Centro Medico AVE ( Site 1704), Monterrey
CaritasKlinikum Saarbrücken St. Theresia ( Site 1211), Saarbrücken
Centro de Investigacion Clinica de Oaxaca ( Site 1705), Oaxaca City
WK Physicians Network / Hematology Oncology Associates ( Site 0034), Shreveport
Texas Oncology - Dallas (Presbyterian) ( Site 0065), Dallas
Hemato Oncologos SA ( Site 0801), Santiago de Cali
Texas Oncology - The Woodlands_Lee ( Site 0043), The Woodlands
HonorHealth ( Site 0041), Phoenix
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren-oncologie ( Site 2907), Limoges
Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1205), Erlangen
Institut Curie - site Saint-Cloud ( Site 2909), Saint-Cloud
Eisenhower Medical Center ( Site 0067), Rancho Mirage
Pacific Cancer Care ( Site 0028), Monterey
Marin Cancer Care ( Site 0055), Greenbrae
Providence Portland Medical Center ( Site 0048), Portland
Beijing Cancer hospital ( Site 0711), Beijing
Beijing Peking Union Medical College Hospital-Gynecological center of tumor ( Site 0702), Beijing
Clínica Universitaria Colombia ( Site 0806), Bogotá
"Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF-Chemotherapy #2 ( Site 2211)", Moscow
The First Hospital of Jilin University ( Site 0710), Changchun
Moscow City Oncology Hospital #62 ( Site 2214), Krasnogorsk D-t
Obstetrics & Gynecology Hospital of Fudan University ( Site 0715), Shanghai
Fudan University Shanghai Cancer Center-Gynecologic Oncology Department ( Site 0701), Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0744), Shanghai
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (, Nanjing
Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0709), Hefei
Shandong Cancer Hospital-Oncology Department ( Site 0733), Jinan
LinYi Cancer Hospital ( Site 0731), Linyi
Tianjin Central Hosptial of Gynecology Obstetrics ( Site 0737), Tianjin
Tianjin Medical University Cancer Institute and Hospital ( Site 0720), Tianjin
The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0706), Wenzhou
Jiangxi Maternal and Child Health Hospital-Oncology Department ( Site 0716), Nanchang
Fujian Provincial Cancer Hospital ( Site 0713), Fuzhou
Xiangya Hospital Central South University-Gynecology ( Site 0705), Changsha
Hunan Cancer Hospital ( Site 0704), Changsha
Ogarev Mordovia State University ( Site 2209), Saransk
Wuhan Union Hospital-Medical Oncology ( Site 0735), Wuhan
Hubei Cancer Hospital-Hubei Cancer Hospital ( Site 0708), Wuhan
Henan Cancer Hospital ( Site 0718), Zhengzhou
Chelyabinsk Regional Clinical Oncology Dispensary-Chelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk
Zhujiang Hospital ( Site 0739), Guangzhou
Affiliated Hospital of Guangdong Medical University ( Site 0743), Zhanjiang
Guangxi Medical University Affiliated Tumor Hospital ( Site 0717), Nanning
Hainan General Hospital ( Site 0736), Haikou
West China Second University Hospital Sichuan University ( Site 0740), Chengdu
SVERDLOVSK REGIONAL ONCOLOGY DISPENSARY-Oncogynecology Department ( Site 2216), Yekaterinburg
Yunnan Province Cancer Hospital-Gynecology Department ( Site 0714), Kunming
Oncologos del Occidente ( Site 0807), Pereira
Lanzhou university second hospital ( Site 0734), Lanzhou
Emek Medical Center-Gyn-Onc ( Site 1406), Afula
The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0741), Hangzhou
Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), Haifa
James Lind Centro de Investigación del Cáncer ( Site 0602), Temuco
CIDO SpA-Oncology ( Site 0608), Temuco
Sheba Medical Center ( Site 1407), Ramat Gan
Clínica Puerto Montt ( Site 0601), Port Montt
Sourasky Medical Center ( Site 1403), Tel Aviv
Oncovida ( Site 0603), Santiago
Instituto de Radiomedicina-hemato-oncologia ( Site 0604), Santiago
Clínica Vespucio-Hemato - Ocology ( Site 0607), Santiago
Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 0609), Santiago
Soroka Medical Center ( Site 1404), Beersheba
Bradfordhill ( Site 0605), Santiago
Shaare Zedek Medical Center ( Site 1405), Jerusalem
ANIMI - Unidade de Tratamento Oncologico ( Site 0408), Lages
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0004), New Haven
University of Massachusetts Chan Medical School-Division of Gynecologic Oncology ( Site 0003), Worcester
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0007), Hackensack
Hospital Araújo Jorge ( Site 0401), Goiânia
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0404), Natal
BP - A Beneficencia Portuguesa de São Paulo ( Site 0403), São Paulo
Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0405), São Paulo
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA-Pesquisa Clinica HC II ( Site 0402), Rio de Janeiro
Tom Baker Cancer Center ( Site 0511), Calgary
BC Cancer Abbotsford ( Site 0512), Abbotsford
BC Cancer Victoria ( Site 0513), Victoria
Kingston Health Sciences Centre-Kingston General Hospital Si-Oncology and/or Hematology - Gynecolog, Kingston
Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0508), Toronto
CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0501), Montreal
Jewish General Hospital ( Site 0505), Montreal
McGill University Health Centre ( Site 0502), Montreal
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec
Saskatoon Cancer Center ( Site 0510), Saskatoon
Zhongda Hospital Southeast University ( Site 0723), Nanjing
Leicester Royal Infirmary-HOPE Clinical Trials Unit ( Site 2812), Leicester
Fundación Colombiana de Cancerología Clínica Vida ( Site 0808), Medellín
Clinica de la Costa LTDA-Clinical Research Oncology & Hematology -Pediatric ( Site 0809), Barranquilla
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden
Universitätsklinikum Leipzig-Department of Gynecology and Obstetrics ( Site 1213), Leipzig
St. James's Hospital-Cancer clinical trials office ( Site 2821), Dublin
Aichi Cancer Center Hospital ( Site 1610), Nagoya
National Cancer Center Hospital East ( Site 1609), Kashiwa
National Hospital Organization Shikoku Cancer Center ( Site 1603), Matsuyama
Ehime University Hospital ( Site 1606), Tōon
Kurume University Hospital ( Site 1607), Kurume
Hokkaido University Hospital ( Site 1604), Sapporo
Iwate Medical University Hospital ( Site 1613), Shiwa-gun Yahaba-cho
Nippon Medical School Musashi Kosugi Hospital ( Site 1614), Kawasaki
Saitama Medical University International Medical Center ( Site 1601), Hidaka-shi
Shizuoka Cancer Center ( Site 1611), Nakatogari
National Cancer Center Hospital ( Site 1612), Chuo-ku
Japanese Foundation for Cancer Research ( Site 1605), Koto
Osaka International Cancer Institute ( Site 1602), Osaka
COI Centro Oncologico Internacional S.A.P.I. de C.V.-Investigation Unit COI ( Site 1703), Mexico City
Radboudumc ( Site 1802), Nijmegen
Leids Universitair Medisch Centrum-Medical Oncology ( Site 1801), Leiden
Erasmus Medisch Centrum-Medical Oncology ( Site 1803), Rotterdam
Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1804), Utrecht
Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Me-Oddzial Ginekologii Onkologicznej ( Sit, Poznan
Szpital Kliniczny im. Księżnej Anny Mazowieckiej ( Site 2103), Warsaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Gynecological Oncology Department ( Sit, Warsaw
Bialostockie Centrum Onkologii-Oddzial Onkologii Ginekologicznej ( Site 2106), Bialystok
Uniwersytecki Szpital Kliniczny w Bialymstoku-Uniwersyteckie Centrum Onkologii ( Site 2104), Bialystok
Uniwersyteckie Centrum Kliniczne-Klinika Ginekologii, Ginekologii Onkologicznej i Endokrynologii Gi, Gdansk
Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 21, Gliwice
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 2107), Kielce
Seoul National University Hospital ( Site 2302), Seoul
Severance Hospital, Yonsei University Health System-Gynecologic cancer center ( Site 2303), Seoul
Asan Medical Center-Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology ( Site 2304), Seoul
Gangnam Severance Hospital ( Site 2301), Seoul
cukurova universty ( Site 2706), Sarçam
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 2704), Adana
Ankara University Hospital Cebeci ( Site 2701), Ankara
Brighton and Sussex University Hospitals NHS Trust ( Site 2803), East Sussex
Addenbrooke's Hospital ( Site 2808), Cambridge
The Royal Cornwall Hospital ( Site 2804), Truro
Westmorland General Hospital ( Site 2815), Kendal
Ninewells Hospital and Medical School ( Site 2826), Dundee
Hammersmith Hospital-Medical Oncology ( Site 2818), London
Velindre Cancer Centre ( Site 2805), Cardiff
Merck Sharp & Dohme LLC
INDUSTRY